HLA-G and breast cancer: Of note, high levels of EV [6] and high levels of a EV sub-population expressing the non-classical human leukocyte antigen-G (HLA-G) [21] have been associated with the failure of neoadjuvant chemotherapy and disease-progression in peripheral blood of locally advanced, primary breast cancer patients.